Novartis Phase III Beovu® data show potential for fluid resolution in more diabetic macular edema patients with fewer injections versus aflibercept

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Suma Ramadas, PhD
Medical Affairs